Abstract Purpose Treatment options in Graves' disease are clearly defined, but management
practices and the perceptions of success are varied. The outcomes of treatment in large …

Abstract Background The management of Graves' disease (GD) in the US is shifting towards
increased use of anti‐thyroid drugs (ATD). If patients fail to achieve remission after a …

Importance Graves disease is the most common cause of persistent hyperthyroidism in
adults. Approximately 3% of women and 0.5% of men will develop Graves disease during …

Background: Considerable uncertainty remains about the pattern of use of treatment options
for Graves' disease (GD) and their comparative effectiveness and safety. Methods: Between …

BACKGROUND: The historical aspects of the pathophysiology and treatment of Graves'
disease are briefly discussed in this paper. MATERIALS AND METHODS: The three …

Context: Several treatment options are available for Graves' disease (GD), including
antithyroid drugs (ATDs), radioactive iodine (RAI), and thyroidectomy. Objective: The primary …

Background: The optimum therapy for Graves' disease (GD) is chosen following discussion
between physician and patient regarding benefits, drawbacks, potential side effects, and …

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas.
Although progress has been made in our understanding of the pathogenesis of the disease …

Background: The treatment efficacy of antithyroid drug (ATD) therapy, radioactive iodine
(131I), or surgery for Graves' hyperthyroidism is well described. However, there are a few …

Objective To investigate the long-term prognosis of patients with Graves' disease (GD) after
antithyroid drug (ATD) treatment and follow-up outside of highly specialised care. Design …